ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 242 filers reported holding ICU MED INC in Q4 2023. The put-call ratio across all filers is 0.56 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $3,837,169 | +57.1% | 32,313 | +42.0% | 0.08% | +64.0% |
Q1 2024 | $2,442,496 | +5.2% | 22,759 | -2.2% | 0.05% | -2.0% |
Q4 2023 | $2,321,449 | -49.0% | 23,275 | -39.2% | 0.05% | -54.1% |
Q3 2023 | $4,553,442 | -80.3% | 38,261 | -70.4% | 0.11% | -79.4% |
Q2 2023 | $23,063,011 | +26.2% | 129,429 | +16.9% | 0.54% | +0.2% |
Q1 2023 | $18,271,794 | -17.9% | 110,765 | -21.6% | 0.54% | -14.5% |
Q4 2022 | $22,258,538 | +1.3% | 141,342 | -3.1% | 0.63% | -2.8% |
Q3 2022 | $21,964,000 | +2.0% | 145,845 | +11.4% | 0.65% | +7.1% |
Q2 2022 | $21,531,000 | -24.0% | 130,978 | +2.9% | 0.60% | -10.0% |
Q1 2022 | $28,332,000 | +12.6% | 127,254 | +20.1% | 0.67% | +26.4% |
Q4 2021 | $25,152,000 | +18.2% | 105,974 | +16.3% | 0.53% | +11.1% |
Q3 2021 | $21,274,000 | +13.8% | 91,154 | +0.4% | 0.48% | +18.7% |
Q2 2021 | $18,693,000 | +1790.1% | 90,833 | +1786.5% | 0.40% | +1910.0% |
Q1 2021 | $989,000 | -80.0% | 4,815 | -79.1% | 0.02% | -82.1% |
Q4 2020 | $4,938,000 | +16.2% | 23,024 | -1.0% | 0.11% | -8.2% |
Q3 2020 | $4,249,000 | +16.3% | 23,249 | +17.3% | 0.12% | +15.1% |
Q2 2020 | $3,652,000 | -13.9% | 19,812 | -5.8% | 0.11% | -32.1% |
Q1 2020 | $4,242,000 | -7.4% | 21,024 | -14.1% | 0.16% | +39.3% |
Q4 2019 | $4,581,000 | -34.1% | 24,480 | -43.8% | 0.11% | -34.9% |
Q3 2019 | $6,947,000 | -51.8% | 43,525 | -23.9% | 0.17% | -49.7% |
Q2 2019 | $14,404,000 | -51.8% | 57,180 | -54.2% | 0.34% | -3.4% |
Q1 2019 | $29,864,000 | +79.5% | 124,780 | +72.2% | 0.35% | -14.3% |
Q4 2018 | $16,641,000 | -18.5% | 72,470 | +0.3% | 0.41% | +8.7% |
Q3 2018 | $20,423,000 | -25.0% | 72,229 | -22.1% | 0.38% | -25.0% |
Q2 2018 | $27,215,000 | +15.7% | 92,680 | -0.5% | 0.51% | +10.7% |
Q1 2018 | $23,516,000 | -19.9% | 93,170 | -31.4% | 0.46% | -12.9% |
Q4 2017 | $29,341,000 | +18.7% | 135,837 | +2.1% | 0.53% | +17.9% |
Q3 2017 | $24,725,000 | +43.4% | 133,039 | +33.1% | 0.45% | +35.6% |
Q2 2017 | $17,238,000 | -6.4% | 99,932 | -17.1% | 0.33% | +2.2% |
Q1 2017 | $18,408,000 | +268.2% | 120,547 | +255.3% | 0.32% | +270.1% |
Q4 2016 | $5,000,000 | +23.4% | 33,932 | -31.4% | 0.09% | +17.6% |
Q4 2014 | $4,052,000 | -43.0% | 49,481 | -55.4% | 0.07% | -46.8% |
Q3 2014 | $7,115,000 | -5.1% | 110,857 | -10.1% | 0.14% | 0.0% |
Q2 2014 | $7,501,000 | -0.6% | 123,344 | -2.2% | 0.14% | -2.1% |
Q1 2014 | $7,550,000 | – | 126,086 | – | 0.14% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sandhill Capital Partners LLC | 91,082 | $20,915,000 | 3.45% |
CROWN ADVISORS MANAGEMENT, INC. | 14,000 | $3,215,000 | 3.34% |
PURA VIDA INVESTMENTS, LLC | 65,119 | $14,953,000 | 2.98% |
Lyon Street Capital, LLC | 11,105 | $2,550,000 | 2.56% |
GW&K Investment Management, LLC | 412,350 | $94,688,000 | 1.87% |
Penn Capital Management Company, LLC | 51,722 | $14,451,000 | 1.43% |
Hotaling Investment Management, LLC | 6,351 | $1,458,000 | 1.19% |
PFM Health Sciences, LP | 175,758 | $40,359,000 | 1.07% |
DIXON HUBARD FEINOUR & BROWN INC/VA | 12,430 | $2,854,000 | 1.06% |
GAM Holding AG | 90,452 | $20,769,000 | 1.05% |